AstraZeneca Pharma India Schedules Board Meeting on 5th Nov'26 to Consider Q2 Results
AstraZeneca Pharma India Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
AstraZeneca Pharma India Schedules Board Meeting on 5th Nov'26 to Consider Q2 Results AstraZeneca Pharma India Limited announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for designated persons remains closed from 16th Sep'26 to 7th Nov'26 (both days inclusive) in compliance with SEBI insider trading regulations.
Original exchange filing (PDF)
More announcements from AstraZeneca Pharma India Ltd
- Please find the enclosed document of the Company as per the captioned subject. This is being resubmitted as the weblink was not correctly re-directing to the relevant web page in the earlier .... 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 07 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about General Updates 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 05 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about Appointment/ Change in designation of Senior Management Personnel 路 05 Nov 2026
